Medscape (10/3, Johnson) reports, “The treatment of major depressive disorder (MDD) should go beyond the goal of symptom relief to include a more global target of improving patients’ overall and occupational functioning,” a shift that “is reflected in new consensus recommendations currently being finalized by the Canadian Network for Mood and Anxiety Treatments (CANMAT).” Network executive chairman Raymond Lam, MD, of the University of British Columbia, told delegates at the Canadian Psychiatric Association’s 62nd Annual Conference, “The ideal outcome really should be functional recovery.”
